Cancer Treatment and Research Communications
Publisher: Elsevier · ISSN 2468-2942 · 85 articles
- Non-coding RNA networks remodeling metastatic signaling in the lung cancer microenvironment: a focus on TGF-β signaling and its crosstalk with Wnt/β-catenin, HIF, Notch, integrin, and CXCL12/CXCR4 pathways
- Diagnostic accuracy of colposcopy-directed biopsy compared with LEEP histology: A retrospective cohort study
- Targeted redox gene-expression profiling reveals shared and distinct expression patterns in HBV- and HCV-associated hepatocellular carcinoma
- The association of the gut microbiome with intermediate markers of breast cancer risk–mammographic density and blood steroid hormones–in the multiethnic cohort study
- Nanosensitizer-based energy therapies for glioblastoma: A systematic review of a four-generation paradigm in evolving strategies (2020-2025)
- Descriptive survival outcomes of fruquintinib-based PD-1 inhibitor strategies in advanced colorectal cancer reported as pMMR/MSS: a reconstructed-data analysis of prospective studies
- Long-term outcomes of a shortened triple-drug regimen for acute promyelocytic leukemia: A 5-year real-world, single-center experience
- Comparative assessment of skin toxicity in prone vs supine positions during postoperative breast radiotherapy: A systematic review and meta-analysis
- Laryngeal cancer burden, risk attribution, and forecasts in mainland China and Taiwan: a Global Burden of Disease 2023 analysis
- CT-guided iodine-125 brachytherapy for advanced thymic epithelial tumors: a preliminary observational study
- Retrospective post-implementation evaluation of an eight-variant BRCA1/2 PCR panel using routine referral data and two Ukrainian NGS cohorts
- Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibroblast subsets associated with survival and tumor microenvironment composition
- Neoadjuvant and perioperative chemoimmunotherapy versus chemotherapy for resectable non-small-cell lung cancer: A systematic review and meta-analysis
- Immune composition and adenosine-associated transcription in non-small-cell lung cancer after neoadjuvant PD-1 blockade
- Patterns of high-risk histopathology features of retinoblastoma in enucleated and exenterated eyes at Tikur Anbessa Specialized Hospital: a retrospective study
- Probiotic modulation of colorectal cancer stemness and metastasis: mechanisms and therapeutic implications
- Beyond RAS G12 grouping: testing treatment-specific prediction after daraxonrasib in pancreatic cancer
- Androgen deprivation therapy for prostate cancer and quality of life: a concept map analysis
- Integrated single-cell and bulk RNA-Seq analysis reveals a LCR-related prognostic signature for precision prognostication and therapeutic stratification in clear cell renal cell carcinoma
- Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with advanced pancreatic adenocarcinoma (RACING)
- Molecular mechanisms of microRNA-92b during tumor progression and metastasis
- Interferon regulation in cancer: tumor vulnerabilities, oncolytic virus exploitation, and emerging immunotherapeutic strategies
- Noncoding RNA regulation of ferroptotic vulnerability in oxaliplatin-resistant colorectal cancer: a critical narrative review beyond the canonical ceRNA model
- ceRNA-mediated regulation of ferroptosis in the lung cancer tumor microenvironment: molecular mechanisms, therapeutic opportunities, and research gaps
- Next-generation chimeric antigen receptor platforms for skin cancer immunotherapy: Biological rationale, therapeutic opportunities, and precision selection strategies
- Inguinal nodal status as the key prognostic factor for survival outcomes in penile cancer
- ACTR5 as a potential therapeutic target in AML: Preliminary mechanistic insights from integrated multi-omics analysis
- Assessment of peripheral and tumor specific Tregs and Th17 cells in patients with endometrial cancer
- In vitro assessment of metabolic inhibition in AGS gastric cancer cells treated with cell-free Lactobacillus gasseri extract
- Safety and efficacy of immune checkpoint inhibitors and hypomethylating agents in treatment-naïve AML and HR-MDS: a systematic review and HR-MDS meta-analysis